Gamma-delta T cells in breast cancer: Dual role in tumor immunity and emerging therapeutic approaches
International Review of Cell and Molecular Biology · 2025
DOI: 10.1016/bs.ircmb.2025.08.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Review of Cell and Molecular Biology, 2025. Verfasst von Silvia Silva-Romeiro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, Virgen Macarena University Hospital, Seville, Spain; Instituto de Biomedicina de Sevilla (IBiS), Virgen Macarena University Hosp…. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Antigen, T-Cell, gamma-delta, Intraepithelial Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Gamma delta (γδ) T cells are a unique subset of T lymphocytes capable of bridging innate and adaptive immunity. Unlike αβ T lymphocytes, γδ T cells bypass the need for Major Histocompatibility Complex (MHC)-restricted antigen presentation, allowing them to rapidly respond to stress signals in contexts such as infections and cancer. In breast cancer (BC), γδ T cells play a dual role, exhibiting both anti-tumoral and pro-tumoral activities. Their capacity for direct cytotoxicity, cytokine production, and antigen presentation highlights their versatility within the tumor microenvironment (TME). The prognostic impact of γδ T cells in BC is complex and varies depending on their density, subset, and functional state. While Vδ1 + γδ T cells have been associated with improved survival, particularly in triple-negative BC, other subsets, such as IL-17-producing γδ T cells, contribute to tumor progression, promoting angiogenesis and immune suppression. The emerging therapeutic potential of γδ T cells resides in their MHC-independent activity and stress antigen recognition, highlighting their potential value in cancer immunotherapy, including adoptive cell therapies (e.g., chimeric antigen receptor-T approaches). Additionally, the combination of γδ T cells with immune checkpoint inhibitors or tumor-targeting antibodies has shown promise in overcoming the immunosuppressive challenges of the TME.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncology Department, Virgen Macarena University Hospital, Seville, Spain; Instituto de Biomedicina de Sevilla (IBiS), Virgen Macarena University Hospital, University of Seville, Seville, Spain.
- Department of Medical Biochemistry and Molecular Biology, School of Medicine, Virgen Macarena University Hospital, University of Seville, Seville, Spain.
- Pathology Department, Virgen Macarena University Hospital, Seville, Spain.
- Instituto de Biomedicina de Sevilla (IBiS), Virgen Macarena University Hospital, University of Seville, Seville, Spain; Department of Medical Biochemistry and Molecular Biology, School of Medicine, Virgen Macarena Unive…
- Oncology Department, Virgen Macarena University Hospital, Seville, Spain; Instituto de Biomedicina de Sevilla (IBiS), Virgen Macarena University Hospital, University of Seville, Seville, Spain. Electronic address: ldela…
Zitieren
APA
Silva-Romeiro, S., Sánchez-León, M. L., Jiménez-Cortegana, C., de Toro-Salas, R., Machuca Aguado, J., Sánchez-Margalet, V., & de la Cruz-Merino, L. (2025). Gamma-delta T cells in breast cancer: Dual role in tumor immunity and emerging therapeutic approaches. International Review of Cell and Molecular Biology. https://doi.org/10.1016/bs.ircmb.2025.08.013
Vancouver
Silva-Romeiro S, Sánchez-León ML, Jiménez-Cortegana C, de Toro-Salas R, Machuca Aguado J, Sánchez-Margalet V, et al. Gamma-delta T cells in breast cancer: Dual role in tumor immunity and emerging therapeutic approaches. International Review of Cell and Molecular Biology. 2025. doi:10.1016/bs.ircmb.2025.08.013
BibTeX
@article{SilvaRomeiro2025,
author = {Silva-Romeiro, Silvia and Sánchez-León, María Luisa and Jiménez-Cortegana, Carlos and de Toro-Salas, Rubén and Machuca Aguado, Jesús and Sánchez-Margalet, Víctor and de la Cruz-Merino, Luis},
title = {Gamma-delta T cells in breast cancer: Dual role in tumor immunity and emerging therapeutic approaches},
journal = {International Review of Cell and Molecular Biology},
year = {2025},
doi = {10.1016/bs.ircmb.2025.08.013}
}
EUVIMED